NPRA Safety Alerts

(Year 2022)

12-May-2022 (No. SP PPUM: 183/2022)

Warfarin

Risk of Anticoagulant-Related Nephropathy (ARN)


Click on the picture for more information.
10-May-2022 (No. SP PPUM: 174/2022)

Hydrochlorothiazide, Chlorthalidone, Indapamide and Acetazolamide

Risk of Choroidal Effusion, Acute Myopia and Acute Angle-Closure Glaucoma


Click on the picture for more information.
09-May-2022 (No. SP PPUM: 173/2022)

Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia

Click on the picture for more information.
08-Apr-2022 (No. SP PPUM: 130/2022)

Betamethasone (Systemic)

Risk of Pheochromocytoma Crisis


Click on the picture for more information.
24-Mar-2022 (No. SP PPUM: 110/2022)

Tenofovir Alafenamide

Risk of Acute Renal Adverse Effects


Click on the picture for more information.
22-Mar-2022 (No. SP PPUM: 105/2022)

Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia

Click on the picture for more information.
20-Jan-2022 (No. SP PPUM: 025/2022)

Clindamycin

Risk of Acute Renal Failure


Click on the picture for more information.
20-Jan-2022 (No. SP PPUM: 020/2022)

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis Patients

Risk of Major Adverse Cardiovascular Events (MACE) and Malignancies [Excluding Non-Melanoma Skin Cancer (NMSC)]


Click on the picture for more information.